EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Pentacistronic Ebola Virus Minigenome System

Brady N Zell iD, Vaille A Swenson, Shao-Chia Lu, Lin Wang, Michael A Barry iD, Hideki Ebihara, Satoko Yamaoka

Viruses · 2025

DOI: 10.3390/v17050688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Brady N Zell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Virology and Gene Therapy Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Ebolavirus, Genome, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, the Mayo Clinic’s Foundation for Medical Education and Research, the National Institutes of Health awarded to VAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ebola virus (EBOV) causes severe disease outbreaks in humans with high case fatality rates. EBOV requires adaptation to cause lethal disease in mice by acquiring single mutations in both the nucleoprotein (NP) and VP24 genes. As an attempt to model mouse-adapted EBOV (MA-EBOV), we engineered novel pentacistronic minigenomes (5xMG) containing a reporter gene, VP40, and glycoprotein genes as well as the NP and VP24 genes from either EBOV or MA-EBOV. The 5xMGs were constructed and optimized, and the produced transcription- and replication-competent virus-like particles (trVLPs) were demonstrated to infect several cell lines. Introduction of the mouse-adaptation mutations did not significantly impact the replication and transcription of the 5xMG or the relative infectivity of the trVLPs in vitro. This work demonstrates the development of the 5xMG system as a new versatile tool to study EBOV biology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EbolavirusGenome, ViralAnimalsMiceHumansVirus ReplicationHemorrhagic Fever, EbolaViral ProteinsCell LineGenes, ReporterNucleoproteins

Stichwörter der Autor:innen

Ebola virusminigenomemouse-adaptationtrVLPs

Substanzen

Viral ProteinsNucleoproteinsVP24 protein, Ebola virus

Autor:innen und Institutionen

  • Virology and Gene Therapy Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA.
  • Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama 208-0011, Japan.

ORCID-Profile: Brady N Zell, Michael A Barry

Förderung

  • NIAID NIH HHS
  • the Mayo Clinic’s Foundation for Medical Education and Research
  • the National Institutes of Health awarded to VAS

Zitieren

APA

Zell, B. N., Swenson, V. A., Lu, S. C., Wang, L., Barry, M. A., Ebihara, H., & Yamaoka, S. (2025). Development of a Pentacistronic Ebola Virus Minigenome System. Viruses. https://doi.org/10.3390/v17050688

Vancouver

Zell BN, Swenson VA, Lu SC, Wang L, Barry MA, Ebihara H, et al. Development of a Pentacistronic Ebola Virus Minigenome System. Viruses. 2025. doi:10.3390/v17050688

BibTeX
@article{Zell2025,
  author = {Zell, Brady N and Swenson, Vaille A and Lu, Shao-Chia and Wang, Lin and Barry, Michael A and Ebihara, Hideki and Yamaoka, Satoko},
  title = {Development of a Pentacistronic Ebola Virus Minigenome System},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17050688}
}
Kostenlos starten →